Publications scientifiques LYSA

Lysa 2022_LYSA_From Stem Cell Transplantation to CAR-T Therapy in Relapse-Refractory Diffuse Large B-Cell Lymphoma

Christian Gisselbrecht, Eric Van Den Neste

doi.org/10.18103/mra.v10i8.3014 En savoir plus

Lysa 2022_LYSA_Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?

Christian Gisselbrecht, David Sibon

doi: 10.1111/bjh.18468 En savoir plus

Lysa 2022_LYSA_Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy. A DESCAR-T analysis

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, René-Olivier Casanovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont

doi: 10.1182/blood.2022016945. En savoir plus

Calym HemSys_Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase

Lise-Marie Mollard, Aurélie Chauveau, Françoise Boyer-Perrard, Nathalie Douet-Guilbert, Roch Houot, Isabelle Quintin-Roué, Marie-Anne Couturier, Anaig Dagorne, Mohamed Malou, Ronan Le Calloch, Odile Luycx, Sylvain Thepot, Mathilde Hunault, Gaelle Guillerm, Christian Berthou, Valérie Ugo, Éric Lippert & Jean-Christophe Ianotto

Leukemia & Lymphoma, 59:12, 2812-2820, DOI: 10.1080/10428194.2018.1441408 En savoir plus

Calym HemSys_IGHV segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies

Jean-Sebastien Allain, Florian Thonier, Morgane Pihan, Marie-Laure Boulland, Sophie de Guibert, Vincent Launay, Anne-Violaine Doncker, Michel Ganard, Amyra Aliouat, Céline Pangault, Roch Houot, Marie De Tayrac, Thierry Lamy, Mikael Roussel, Thierry Fest, Olivier Decaux, Cedric Pastoret

Haematologica 2018;103(5):e207-e210; https://doi.org/10.3324/haematol.2017.177444. En savoir plus

Calym HemSys_Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome

L. Alix, A. Néel, B. Cador, A. Smail, J. Serratrice, F. Closs-Prophette, P. Jego, A. Devillers & O. Decaux

Autoimmunity, 52:7-8, 264-271, DOI: 10.1080/08916934.2019.1680649 En savoir plus

Calym HemSys_Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)

Durot, E., Tomowiak, C., Michallet, A.-S., Dupuis, J., Hivert, B., Leprêtre, S., Toussaint, E., Godet, S., Merabet, F., Van Den Neste, E., Ivanoff, S., Roussel, X., Zini, J.-M., Regny, C., Lemal, R., Sutton, L., Perrot, A., Le Dû, K., Kanagaratnam, L., Morel, P., Leblond, V. and Delmer, A.

Br J Haematol, 179: 439-448. https://doi.org/10.1111/bjh.14881 En savoir plus

HemSys_Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

Reboursiere E., Bras F., Herbaux C., Gyan E., Clavert A., Morschhauser F., Malak S., Sibon D., Broussais F., Braun T., Fornecker L., Garidi R., Tricot S., et al

Oncotarget. 2016; 7: 85573-85583. Retrieved from https://www.oncotarget.com/article/10764/text/ En savoir plus

Calym HemSys_Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life

Norwood, J., Pastoret, C., Luycx, O., Le Coz, M.-F., Moreau, P., Trebouet, A., Niault, M., Launay, V., Allangba, O., Bareau, B., Doncker, V., Grulois, I., Jacomy, D., Le Dû, K., Henry, C., Le Pabic, E., Boulland, M.-L., Fest, T., Lamy, T. and Escoffre-Barbe, M.

Am J Hematol, 93: E329-E331. https://doi.org/10.1002/ajh.25217 En savoir plus

Calym HemSys_Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement

Mercier M, Orvain C, Drieu La Rochelle L, Marchand T, Nunes Gomes C, Giltat A, Paillassa J, Clavert A, Farhi J, Rousselet M-C, Gyan E, Houot R, Moles-Moreau M-P, Hunault-Berger M.

Cancers 2021, 13(12), 2945; https://doi.org/10.3390/cancers13122945 En savoir plus

Calym HemSys_Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain, Hervé Ghesquières, Olivier Chinot, Luc Taillandier, Pierre Soubeyran, Thierry Lamy, Franck Morschhauser, Alexandra Benouaich-Amiel, Guido Ahle, Marie-Pierre Moles-Moreau, Cécile Moluçon-Chabrot, Pascal Bourquard, Ghandi Damaj, Fabrice Jardin, Delphine Larrieu, Emmanuel Gyan, Remy Gressin, Arnaud Jaccard, Sylvain Choquet, Annie Brion, Olivier Casasnovas, Philippe Colin, Oumedaly Reman, Adrian Tempescul, Jean-Pierre Marolleau, Michel Fabbro, Florian Naudet, Khê Hoang-Xuan, Roch Houot

Neuro-Oncology, Volume 18, Issue 9, September 2016, Pages 1297–1303, https://doi.org/10.1093/neuonc/now033 En savoir plus

Calym HemSys_Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study

Isabelle Fleury, Sandy Amorim, Nicolas Mounier, Bertrand Coiffier, Jehan Dupuis, Hervè Tilly, Mohamed A. Mazari, Lauriane Filliatre, Josette Brière, Pauline Brice, Eric de Kerviler & Catherine Thieblemont

Leukemia & Lymphoma, 56:7, 2025-2031, DOI: 10.3109/10428194.2014.977884 En savoir plus

Lysa 2022_LYSA_A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Manson, Guillaume Cartron, David Beauvais, Louise Roulin, François Xavier Gros, Marie Thérèse Rubio, Pierre Bories, Jacques Olivier Bay, Cristina Castilla Llorente, Sylvain Choquet, René-Olivier Casasnovas, Mohamad Mohty, Stéphanie Guidez, Magalie Joris, Michaël Loschi, Sylvain Carras, Julie Abraham, Adrien Chauchet, Laurianne Drieu La Rochelle, Bénédicte Deau-Fischer, Olivier Hermine, Thomas Gastinne, Jean Jacques Tudesq, Elodie Gat, Florence Broussais, Catherine Thieblemont, Roch Houot & Franck Morschhauser

doi: 10.1038/s41591-022-01969-y. En savoir plus

Lysa 2022_LYSA_PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells

Jean Galtier, Laetitia Vercellino, Loic Chartier, Pierre Olivier, Claire Tabouret-Viaud, Charles Mesguich, Roberta Di Blasi, Amandine Durand, Léo Raffy, François-Xavier Gros, Isabelle Madelaine, Veronique Meignin, Miryam Mebarki, Marie-Thérèse Rubio, Pierre Feugier, Olivier Casasnovas, Michel Meignan, Catherine Thieblemont

doi: 10.3324/haematol.2021.280550. En savoir plus

Lysa 2022_LYSA_Interpretation of 2-[ 18 F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors

Manson G, Lemchukwu AC, Mokrane FZ, Lopci E, Aide N, Vercellino L, Houot R, Dercle L.

Eur Radiol . 2022 Sep;32(9):6536-6544. En savoir plus

Lysa 2022_LYSA_Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

Nicolae A, Bouilly J, Lara D, Fataccioli V, Lemonnier F, Drieux F, Parrens M, Robe C, Poullot E, Bisig B, Bossard C, Letourneau A, Missiaglia E, Bonnet C, Szablewski V, Traverse-Glehen A, Delfau-Larue MH, de Leval L, Gaulard P

Mod Pathol . 2022 Aug;35(8):1126-1136. En savoir plus

Lysa 2022_LYSA_Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R; Lymphoma Study Association (LYSA).

Br J Haematol . 2022 Jul;198(1):203-206. En savoir plus

Lysa 2022_LYSA_Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Amira Marouf, Anne-Ségolène Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, Patricia Franchi, David Sibon, Clara Antoine, Thomas Gastine, Cecile Borel, Mohammad Hammoud, Guillaume Sicard, Romane Gille, Doriane Cavalieri, Aspasia Stamatoullas, Lauriane Filliatre-Clement, Julien Lazarovici, Adrien Chauchet, Luc-Matthieu Fornecker, Sandy Amorin, Mathieu Rocquet, Nicolae Raus, Barbara urroni, Marie-Thérèse Rubio, Didier Bouscary, Pilippe Quittet, René-Olivier Casanovas, Pauline Brice, Hervé Guesquieres, Jerome Tamburini, Benedicte Deau

Haematologica . 2022 Jul 1;107(7):1681-1686. En savoir plus

Lysa 2022_LYSA_Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with Mantle Cell lymphoma, a LYSA retrospective study

Domitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne, Catherine Thieblemont, Lucie Oberic, Krimo Bouabdallah, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Dartigeas, vincent ribrag, Patrick Fogarty, René-Olivier Casasnovas, Roch Houot, Caroline Delette, Sandra Malak, Luc-Matthieu Fornecker, Remy Gressin, Gandhi Damaj, and Steven Le Gouill

Bone Marrow Transplant . 2022 Apr;57(4):627-632. En savoir plus

Lysa 2022_LYSA_The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Baptiste Eluard, Stéphanie Nuan-Aliman, Nathalie Faumont, Davi Collares, Didier Bordereaux, Aurélie Montagne, Isabelle Martins, Nicolas Cagnard, Martial Caly, Oussama Taoui, Leonardo Lordello, Jacqueline Lehmann-Che, Bruno Tesson, Jose-Angel Angel Martinez-Climent, Christiane Copie-Bergman, Corinne Haioun, Herve Tilly, Benjamin Bonsang, Anne Vincent-Salomon, Jean-Philippe Jais, Fabrice Jardin, Karen Leroy, Maria Chiara Maiuri, Guido Kroemer, Thierry Jo Molina, Jean Feuillard, Véronique Baud

Blood . 2022 Jan 20;139(3):384-398. En savoir plus

Lysa 2022_LYSA_Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study

Aspasia Stamatoullas, Hervé Ghesquières, Pierre Feugier, Marc André, Fabien Le Bras, Anne-Claire Gac, Cécile Borel, Thomas Gastinne, Philippe Quittet, Franck Morschhauser, Vincent Ribrag, Stephanie Guidez, Emmanuelle Nicolas-Virelizier, Alina Berriolo-Riedinger, Thierry Vander Borght, Véronique Edeline, Pauline Brice

doi: 10.1080/10428194.2022.2107204. En savoir plus

Lysa 2022_LYSA_Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

Franck Morschhauser, Loretta Nastoupil, Pierre Feugier, Jean-Marc Schiano de Colella, Hervé Tilly, Maria Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward N Libby, Rene-Olivier Casasnovas, Ian W Flinn, Corinne Haioun, Hervé Maisonneuve, Loic Ysebaert, Nancy L Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Stéphanie Guidez, Gian Matteo Pica, Alejandro Martín García-Sancho, Armondo López-Guillermo, Jean-François Larouche, Kiyoshi Ando, Maria Gomes da Silva, Marc André, Wu Kalung, Laurie H Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan H Fowler, Gilles Salles

J Clin Oncol . 2022 Aug 10;JCO2200843. En savoir plus

Lysa 2022_LYSA_Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, Rene-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Krimo Bouabdallah, Pierre Feugier, Lena Specht, Lysiane Molina, Mohamed Touati, Cecile Borel, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Laurent Pascal, Pieternella Lugtenburg, Nicola Di Renzo, Thierry Vander Borght, Alexandra Traverse-Glehen, Peggy Dartigues, Martin Hutchings, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, for the LYSA-FIL-EORTC Intergroup

doi: 10.1200/JCO.21.01281. En savoir plus

Lysa 2022_LYSA_High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline

Rossi C, André M, Dupuis J, Morschhauser F, Joly B, Lazarovici J, Ghesquières H, Stamatoullas A, Nicolas-Virelizier E, Feugier P, Gac AC, Moatti H, Fornecker LM, Deau B, Joubert C, Fortpied C, Raemaekers J, Federico M, Kanoun S, Meignan M, Traverse-Glehen A, Cottereau AS, Casasnova RO

doi: 10.3324/haematol.2021.280004 En savoir plus

Lysa 2022_LYSA_Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Vincent Camus, Aurelien Belot, Lucie Obéric, David Sibon, Herve Ghesquieres, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Molina, Andre Bosly, Clementine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Herve Tilly

10.1182/bloodadvances.2022007609. En savoir plus

Lysa 2022_LYSA_Oncogenetic landscape of lymphomagenesis in coeliac disease

Sascha Cording, Ludovic Lhermitte, Georgia Malamut, Sofia Berrabah, Amélie Trinquand, Nicolas Guegan, Patrick Villarese, Sophie Kaltenbach, Bertrand Meresse, Sherine Khater, Michael Dussiot, Marc Bras, Morgane Cheminant, Bruno Tesson, Christine Bole-Feysot, Julie Bruneau, Thierry Jo Molina, David Sibon, Elizabeth Macintyre, Olivier Hermine, Christophe Cellier, Vahid Asnafi, Nadine Cerf-Bensussan, CELAC network

Gut . 2022 Mar;71(3):497-508. En savoir plus

Lysa 2022_LYSA_PET-driven strategy in advanced Hodgkin lymphoma: prolonged follow-up of the AHL2011 Phase III LYSA study

René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspasia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Franck Morschhauser, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi

J Clin Oncol . 2022 Apr 1;40(10):1091-1101. En savoir plus

Lysa 2022_LYSA_Lenalidomide-induced arthritis: A case report and review of literature and pharmacovigilance databases

Charlotte Icard, Pauline Mocquot, Jean-Claude Nogaro, Fabien Despas, Martin Gauthier

J Oncol Pharm Pract . 2022 Mar;28(2):453-456. En savoir plus

Lysa 2022_LYSA_Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials

Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard Hochster, Wolfgang Hiddemann, Robert E Marcus, Eva K Kimby, Michael Herold, Catherine J Sebban, Emmanuel Gyan, Kenneth A Foon, Tina G Nielsen, Umberto Vitolo, Gilles Andre Salles, Qian Shi, Christopher R Flowers

Blood . 2022 Mar 17;139(11):1684-1693. En savoir plus

Lysa 2022_LYSA_A guide to ComBat harmonization of imaging biomarkers in multicenter studies

Fanny Orlhac, Jakoba J. Eertink, Anne-Ségolène Cottereau, Josée M. Zijlstra, Catherine Thieblemont, Michel Meignan, Ronald Boellaard, Irène Buvat

J Nucl Med . 2022 Feb;63(2):172-179. En savoir plus

Lysa 2022_LYSA_Deep Learning approach to automatize TMTV calculation regardless of segmentation methodology for main FDG avid lymphomas

Wendy Revailler, Anne-Ségolène Cottereau, Cédric Rossi, Rudy Noyelle, Thomas Trouillard, Franck Morschhauser, Rene-Olivier Casasnovas, Catherine Thieblemont, Steven Le Gouill, Marc P-E André, Hervé Ghesquières, Romain Ricci, Michel Meignan, Salim Kanoun

Diagnostics (Basel) . 2022 Feb 6;12(2):417. En savoir plus

Lysa 2022_LYSA_Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

Roch Houot, Viola Poeschel, Bettina Altmann, Stephanie Angel, Lorenz Thurner, Thomas Illmer, Marc Andre, Martin Dreyling, Hervé Maisonneuve, Hervé Tilly, Stephanie Mayer, Olivier Casasnovas, Steven Le Gouill, Fritz Offner, Guillaume Cartron, Andrea Kerkhoff, Thomas Weber, Joerg Hoffmann, Marita Ziepert, Wolfram Klapper, Emmanuel Itti, Dirk Hellwig, Giorgi Natchkebia, Laurence de Leval, Andreas Rosenwald, Corinne Haioun, Laurent Dercle, Philippe Gaulard, Gerhard Held

Hemasphere . 2022 Jan 10;6(2):e672. En savoir plus

Lysa 2022_LYSA_Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

Alexandra‑Cristina Paunescu, Christiane Copie Bergman, Sandra Malak, Steven Le Gouill, Vincent Ribrag, Krimo Bouabdallah, David Sibon, Gerhard Rumpold, Marie Preau, Nicolas Mounier, Corinne Haioun, Fabrice Jardin, Caroline Besson

Ann Hematol . 2022 Feb;101(2):317-332. En savoir plus

Lysa 2022_LYSA_Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group

Christophe Bonnet, Jehan Dupuis, Hervé Tilly, Thierry Lamy, Christophe Fruchart, Steven le Gouill, Catherine Thieblemont, Franck Morschhauser, Olivier Casasnovas, Krimo Bouabdallah, Hervé Ghesquieres, Eric Van Den Neste, Marc André, Guillaume Cartron, Gilles Salles

Cancers (Basel) 2022 Mar 30;14(7):1761. doi: 10.3390/cancers14071761. En savoir plus

Lysa 2022_LYSA_Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study

Virginie Nerich, Christophe Guyeux, Michel Henry-Amar, Raphaël Couturier, Catherine Thieblemont, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Franck Morschhauser, Pierre Feugier, David Sibon, Loic Ysebaert, Emmanuelle Nicolas-Virelizier, Florence Broussais-Guillaumot, Gandhi L Damaj, Jean-Philippe Jais, Gilles Salles, Macha Woronoff-Lemsi, Nicolas Mounier

Cancer . 2022 Feb 1;128(3):519-528. doi: 10.1002/cncr.33938. En savoir plus

Lysa 2022_LYSA_Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Emmanuel Bachy; Vincent Camus; Catherine Thieblemont; David Sibon; René-Olivier Casasnovas; Loïc Ysebaert; Gandhi Damaj; Stéphanie Guidez; Gian Matteo Pica; Won Seog Kim; Soon Thye Lim; Marc André; Alejandro Martín García-Sancho; Maria Jesus Penarrubia; Philipp B. Staber; Judith Trotman; Andreas Hüttmann; Vittorio Stefoni; Alessandro Re; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Michel Meignan; Ju Li; Franck Morschhauser; and Richard Delarue

J Clin Oncol . 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. En savoir plus

Lysa 2022_LYSA_Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Hervé Tilly, Franck Morschhauser, Laurie H Sehn, Jonathan W Friedberg, Marek Trněný, Jeff P Sharman, Charles Herbaux, John M Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan M Bergua-Burgués, Matthew C Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R Flowers, Gilles Salles

N Engl J Med . 2022 Jan 27;386(4):351-363. doi: 10.1056/NEJMoa2115304. En savoir plus

Lysa 2022_LYSA_Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA

Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Pauline Brice, David Sibon, Jean Marc Schiano, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Baptiste Delapierre, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Caroline Besson, Eric Durot, Christophe Bonnet, Ludovic Fouillet, Fontanet Bijou, Oliver Tournilhac, Philippe Gaulard, Marie-Cécile Parrens, Gandhi Damaj on behalf of the LYSA group

DOI: 10.1182/bloodadvances.2022008524 En savoir plus

Lysa 2022_LYSA_Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials

Valeria Fiaccadori, Anouk Neven, Catherine Fortpied, Igor Aurer, Marc Andre, Massimo Federico, Nicholas Counsell, Elizabeth H Phillips, Laura Clifton-Hadley, Sally F Barrington, Timothy Illidge, John Radford, John M M Raemaekers

DOI: 10.1111/bjh.18594 En savoir plus

Lysa 2022_LYSA_ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study

David Sibon, Bettina Bisig, Christophe Bonnet, Elsa Poullot, Emmanuel Bachy, Doriane Cavalieri, Virginie Fataccioli, Cloe Bregnard, Fanny Drieux, Julie Bruneau, Francois Lemonnier, Aurelie Dupuy, Celine Bossard, Marie Parrens, Krimo Bouabdallah, Nicolas Ketterer, Gregoire Berthod, Anne Cairoli, Gandhi Damaj, Olivier Tournilhac, Jean-Philippe Jais, Philippe Gaulard, Laurence De Leval

DOI: 10.3324/haematol.2022.281442 En savoir plus

Lysa 2022_LYSA_Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study

Georg Hess, Martin Dreyling, Lucie Oberic, Eva Gine, Pier Luigi Zinzani, Kim Linton, Adam Vilmar, Mats Jerkeman, Jenny M H Chen, Anke Ohler, Stephan Stilgenbauer, Catherine Thieblemont, Jonathan Lambert, Vittorio Ruggero Zilioli, Juan-Manuel Sancho, Ana Jiménez-Ubieto, Luca Fischer, Toby A Eyre, Sam Keeping, Julie E Park, James J Wu, Rubina Siddiqi, John Reitan, Sally Wade, Gilles Salles

DOI: 10.1111/bjh.18519 En savoir plus

Lysa 2022_LYSA_Molecular Monitoring of Lymphomas

Joseph G. Schroers-Martin, Stefan Alig, Andrea Garofalo, Benoit Tessoulin, Takeshi Sugio, Ash A. Alizadeh

DOI: 10.1146/annurev-pathol-050520-044652 En savoir plus

Lysa 2022_LYSA_European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL)

Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri , Julia Furtner, Jaime Gallego Perez-Larraya, Roger Henriksson, Andreas F Hottinger, Benjamin Kasenda, Florence Lefranc, Alexander Lossos, Catherine McBain, Matthias Preusser, Patrick Roth, Roberta Rudà, Uwe Schlegel, Riccardo Soffietti, Carole Soussain, Martin J B Taphoorn, Valérie Touitou, Michael Weller, Jacoline E C Bromberg

DOI: 10.1093/neuonc/noac196 En savoir plus

Lysa 2022_LYSA_Application of The Lugano Classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2- Technical)

Fabien Ricard, Sally Barrington, Ron Korn, Guenther Brueggenwerth, Judith Trotman, Bruce Cheson, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann, Annette Schmid

DOI: 10.2967/jnumed.122.264124 En savoir plus

Lysa 2022_LYSA_Application of The Lugano Classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1- Clinical)

Fabien Ricard, Bruce Cheson, Sally Barrington, Judith Trotman, Annette Schmid, Guenther Brueggenwerth, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Florence Broussais, Jayant Narang, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann, Ron Korn

DOI: 10.2967/jnumed.122.264106 En savoir plus

Lysa 2022_LYSA_Influence of Sociodemographic Determinants on the Hodgkin Lymphoma Baseline Characteristics in Long Survivors Patients Enrolled in the Prospective Phase 3 Trial AHL2011

Steeve Chevreux, Sandra de Barros, Camille Laurent, Amandine Durand, Cyrille Delpierre, Philippine Robert, Clémentine Joubert, Samuel Griolet, Salim Kanoun, Jean-Noël Bastie, René-Olivier Casasnovas, Cédric Rossi

doi: 10.3390/cancers15010053 En savoir plus

Lysa 2022_LYSA_Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France

Marie Donzel, Maxime Bonjour, Jean-Damien Combes, Florence Broussais, Pierre Sesques, Alexandra Traverse-Glehen, Catherine de Martel

DOI: 10.1016/j.eclinm.2022.101674 En savoir plus

Lysa 2022_LYSA_Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP

Julia Driessen, Marie José Kersten, Lydia Visser, Anke van den Berg, Sanne H Tonino, Josée M Zijlstra, Pieternella J Lugtenburg, Franck Morschhauser, Martin Hutchings, Sandy Amorim, Thomas Gastinne, Marcel Nijland, Gerben J C Zwezerijnen, Ronald Boellaard, Henrica C W de Vet, Anne I J Arens, Roelf Valkema, Roberto D K Liu, Esther E E Drees, Daphne de Jong, Wouter J Plattel, Arjan Diepstra; HOVON Lunenburg Lymphoma Phase I/II Consortium (LLPC)

DOI: 10.1038/s41375-022-01717-8 En savoir plus

Lysa 2022_LYSA_18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients

Kibrom B Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont, Irène Buvat

DOI: 10.2967/jnumed.121.263501 En savoir plus

Lysa 2022_LYSA_A tumor volume and performance status model to predict outcome prior to treatment in diffuse large B-cell lymphoma

Catherine Thieblemont, Loic Chartier, Ulrich Duhrsen, Umberto Vitolo, Sally Barrington, Jan Zaucha, Laetitia Vercellino, Maria Gomes da Silva, Ines Patrocinio-Carvalho, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, Alina Berriolo-Riedinger, Olivier Casasnovas, Andreas Hüttmann, Hajira Ilyas, N. George Mikhaeel, Joel Dunn, Anne-Ségolène Cottereau, Christine Schmitz, Lale Kostakoglu, Joseph Paulson, Tina Nielsen, Michel Meignan

DOI: 10.1182/bloodadvances.2021006923 En savoir plus

Lysa 2022_LYSA_Finding a consensus on time-to-event endpoints definitions in marginal zone lymphoma: A Delphi method

Côme Bommier, Jérôme Lambert, Grzegorz Nowakowski, Emanuele Zucca, Catherine Thieblemont

DOI: 10.1002/hon.2988 En savoir plus

Lysa 2022_LYSA_Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma

Juan Pablo Alderuccio, Isildinha M Reis, Thomas M Habermann, Brian K Link, Catherine Thieblemont, Annarita Conconi, Melissa C Larson, Luciano Cascione, Wei Zhao, James R Cerhan, Emanuele Zucca, Izidore S Lossos

DOI: 10.1002/ajh.26715 En savoir plus

Lysa 2022_LYSA_Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study

Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, Carmen Botella-Garcia, Micha Srour, Steven Le Gouill, Gaelle Guillerm, Rémy Gressin, Stéphanie Nguyen Quoc, Sabine Furst, Adrien Chauchet, David Sibon, Philippe Lewalle, Xavier Poiré, Natacha Maillard, Alban Villate, Michael Loschi, Jérôme Paillassa, Yves Beguin, Rémy Dulery, Jean-Jacques Tudesq, Amandine Fayard, Marie C Béné, Vincent Camus, Patrice Chevallier, Amandine Le Bourgeois

DOI: 10.1080/0284186X.2022.2130709 En savoir plus

Lysa 2022_LYSA_Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak

Milena Kohn, Tamim Alsuliman, Sylvain Lamure, Morgane Cheminant, Jéremy Delage, Corinne Merle De Boever, Jean Jacques Tudesq, Zora Marjanovic, Zoé Van de Wyngaert, Florent Malard, Eolia Brissot, Sophie Rigaudeau, Stéphanie Marque-Juillet, Audrey Therby, Guillaume Cartron, Philippe Rousselot, Olivier Hermine, Rémy Duléry, Caroline Besson

DOI: 10.1080/10428194.2022.2086249 En savoir plus

Lysa 2022_LYSA_Genomic profiling for clinical decision making in lymphoid neoplasms

Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz,Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. LaCasce, Georg Lenz, Jose I. Martin-Subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott

DOI: 10.1182/blood.2022015854 En savoir plus

Lysa 2022_LYSA_Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population

Samuel Vic, Jean Lemoine, Philippe Armand, François Lemonnier, Roch Houot

DOI: 10.1016/j.ejca.2022.08.019 En savoir plus

Lysa 2022_LYSA_Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study

Rexhep Durmo, Benedetta Donati, Louis Rebaud, Anne Segolene Cottereau, Alessia Ruffini, Maria Elena Nizzoli, Sabino Ciavarella, Maria Carmela Vegliante, Christophe Nioche, Michel Meignan, Francesco Merli, Annibale Versari, Alessia Ciarrocchi, Irene Buvat, Stefano Luminari

DOI: 10.1002/hon.3025 En savoir plus

Lysa 2022_LYSA_Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper

Sarah Bailly, Guillaume Cartron, Sridhar Chaganti, Raul Córdoba, Paolo Corradini, Johannes Düll, Isacco Ferrarini, Wendy Osborne, Andreas Rosenwald, Juan-Manuel Sancho, Hervé Tilly, Eric Van Den Neste, Andreas Viardot, Carlo Visco

DOI: 10.1002/hon.3013 En savoir plus

Lysa 2022_LYSA_Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma

Clément Bailly, Thomas Carlier, Benoit Tessoulin, Thomas Gastinne, Françoise Kraeber-Bodere, Steven Le Gouill, Caroline Bodet-Milin

DOI: 10.1002/hon.2965 En savoir plus

Lysa 2022_LYSA_Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study

Antoine Bonnet, Céline Bossard, Ludovic Gabellier, Julien Rohmer, Othman Laghmari, Marie Parrens, Clémentine Sarkozy, Rémy Dulery, Virginie Roland, Francisco Llamas-Gutierrez, Lucie Oberic, Luc-Matthieu Fornecker, Laura Bounaix, Bruno Villemagne, Vanessa Szablewski, Sylvain Choquet, Krimo Bouabdallah, Alexandra Traverse-Glehen, Mohamad Mohty, Laurence Sanhes, Roch Houot, Thomas Gastinne, Christophe Leux, Steven Le Gouill

DOI: 10.1002/cam4.4742 En savoir plus

Lysa 2022_LYSA_Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie Jose Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong

DOI: 10.1182/bloodadvances.2022008355 En savoir plus

Lysa 2022_LYSA_The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo 1, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Salles, Jesus San-Miguel, John F Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew Davies, Brunangelo Falini, Irene M Ghobrial, John R Goodlad, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji Kumar, Ann S LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria Victoria Mateos, Elizabeth Macintyre, Ari M Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier-Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz

DOI: 10.1182/blood.2022015851 En savoir plus

Lysa 2022_LYSA_Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma

Diego Villa, Eva Hoster, Olivier Hermine, Wolfram Klapper, Michal Szymczyk, Andre Bosly, Michael Unterhalt, Lisa M. Rimsza, Colleen A. Ramsower, Ciara L. Freeman, David W. Scott, Alina S. Gerrie, Kerry J. Savage, Laurie H. Sehn, Martin Dreyling

DOI: 10.1182/bloodadvances.2022007371 En savoir plus

Lysa 2022_LYSA_Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma

Louise Bouard, Benoit Tessoulin, Catherine Thieblemont, Kamal Bouabdallah, Thomas Gastinne, Lucie Oberic, Sylvain Carras, Caroline Delette,Olivier Casasnovas, Caroline Dartigeas, Victoria Cacheux, Sibylle Masse, Olivier Hermine, Steven Le Gouill

DOI: 10.3324/haematol.2021.279561 En savoir plus

Lysa 2022_LYSA_Chapter 15: Indolent Lymphomas

Franck Morschhauser, Pier Luigi Zinzani.

DOI: 10.1007/978-3-030-94353-0_15 En savoir plus

Lysa 2022_LYSA_The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici , Amy Chadburn , John K C Chan, Wah Cheuk 12, Wee-Joo Chng, John K Choi, Shih-Sung Chuang, Sarah E Coupland, Magdalena Czader, Sandeep S Dave, Daphne de Jong, Ming-Qing Du, Kojo S Elenitoba-Johnson, Judith Ferry, Julia Geyer, Dita Gratzinger, Joan Guitart, Sumeet Gujral, Marian Harris, Christine J Harrison, Sylvia Hartmann, Andreas Hochhaus, Patty M Jansen, Kennosuke Karube, Werner Kempf, Joseph Khoury, Hiroshi Kimura, Wolfram Klapper, Alexandra E Kovach, Shaji Kumar, Alexander J Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao-Qiu Li, Megan S Lim, Wei-Ping Liu, Abner Louissaint Jr, Andrea Marcogliese, L Jeffrey Medeiros, Michael Michal, Roberto N Miranda, Christina Mitteldorf, Santiago Montes-Moreno, William Morice, Valentina Nardi, Kikkeri N Naresh, Yasodha Natkunam, Siok-Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S Vincent Rajkumar, Andrew C Rawstron, Karen Rech, Andreas Rosenwald, Jonathan Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William Sewell, Reiner Siebert, Aliyah R Sohani, Reuben Tooze, Alexandra Traverse-Glehen, Francisco Vega, Beatrice Vergier, Ashutosh D Wechalekar, Brent Wood, Luc Xerri, Wenbin Xiao

DOI: 10.1038/s41375-022-01620-2 En savoir plus

Lysa 2022_LYSA_End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma

Jesse G Dixon, Natalie Dimier, Tina Nielsen, Jamie Zheng, Robert Marcus, Franck Morschhauser, Andrew M Evens, Massimo Federico, Kristie A Blum, Qian Shi

DOI: 10.1111/bjh.18217 En savoir plus

Lysa 2022_LYSA_Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials

Côme Bommier, Mathilde Ruggiu, Aymeric Monégier, Emanuele Zucca, Catherine Thieblemont, Jérôme Lambert

DOI: 10.1080/10428194.2022.2032038 En savoir plus

Lysa 2022_LYSA_Chemotherapy-free treatment in unfit patients aged 75 years and older with DLBCL: toward a new paradigm?

Fabrice Jardin, Hervé Tilly

DOI: 10.1016/S2666-7568(22)00150-7 En savoir plus

Lysa 2022_LYSA_Peripheral T-Cell Lymphomas: Therapeutic Approaches

David Sibon

DOI: 10.3390/cancers14092332 En savoir plus

Lysa 2022_LYSA_The EHA Research Roadmap: Malignant Lymphoid Diseases

Martin Dreyling, Marc André, Nicola Gökbuget, Hervé Tilly, Mats Jerkeman, John Gribben, Andrés Ferreri, Pierre Morel, Stephan Stilgenbauer, Christopher Fox, José Maria Ribera, Sonja Zweegman, Igor Aurer, Csaba Bödör, Birgit Burkhardt, Christian Buske, Maria Dollores Caballero, Elias Campo, Bjoern Chapuy, Andrew Davies, Laurence de Leval, Jeanette Doorduijn, Massimo Federico, Philippe Gaulard, Francesca Gay, Paolo Ghia, Kirsten Grønbæk, Hartmut Goldschmidt, Marie-Jose Kersten, Barbara Kiesewetter, Judith Landman-Parker, Steven Le Gouill, Georg Lenz, Sirpa Leppä, Armando Lopez-Guillermo, Elizabeth Macintyre, Maria Victoria Mateos Mantega, Philippe Moreau, Carol Moreno, Bertrand Nadel, Jessica Okosun, Roger Owen, Sarka Pospisilova, Christiane Pott, Tadeusz Robak, Michelle Spina, Kostas Stamatopoulos, Jan Stary, Karin Tarte, Allessandra Tedeschi, Catherine Thieblemont, Ralf Ulrich Trappe, Lorenz H. Trümper, Gilles Salles

DOI: 10.1097/HS9.0000000000000726 En savoir plus

Lysa 2022_LYSA_Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality

Adrien Krug, Gamze Tari, Aymen Saidane, Philippe Gaulard, Jean-Ehrland Ricci, François Lemonnier, Els Verhoeyen

DOI: 10.3390/cancers14102392 En savoir plus

Lysa 2022_LYSA_Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Matthew R. Wilson, Toby A. Eyre, Amy A. Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolás Martinez-Calle, Gavin Preston, Matthew Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L. Lewis, Teresa Calimeri, Eric Durot, Loïc Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Timothy J. Ebsworth, Johnathan Elliot, Anna Santarsieri, Laure Ricard, Nimish Shah, Qin Liu, Adam S. Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish Scott, Anna Guidetti, Brett R. Barlow, Emmanuelle Tchernonog, Jeffery Smith, Fiona Miall, Christopher P. Fox, Chan Y. Cheah, Tarec Christoffer El Galaly, Andrés J. M. Ferreri, Kate Cwynarski, Pamela McKay

DOI: 10.1182/blood.2021014506 En savoir plus

Lysa 2022_LYSA_The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target‑Mediated Drug Disposition

Amina Bensalem, Guillaume Cartron, Ulrich Specks, Denis Mulleman, Emmanuel Gyan, Divi Cornec, Celine Desvignes, Olivier Casasnovas, Thierry Lamy, Stéphane Leprêtre, Gilles Paintaud, David Ternant

DOI: 10.1007/s40262-021-01081-3 En savoir plus

Lysa 2022_LYSA_Chapter 22: Bridging Chemotherapy: Relapsed/Refractory Aggressive B-Cell Lymphoma

Catherine Thieblemont, Peter Borchmann

DOI: 10.1007/978-3-030-94353-0_22 En savoir plus

Lysa 2022_LYSA_Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma

Kamel Laribi, Alix Baugier de Materre, Yamina Touileb, Charles Boursot, Jeremy Sandrini, Doriane Cavalieri, Cédric Pastoret, Laurence de Leval, Olivier Tournilhac

DOI: 10.1097/HS9.0000000000000675 En savoir plus

Lysa 2022_LYSA_What Prognostic Markers Should Be Evaluated in Marginal Zone Lymphoma? A Survey Among Leading International Experts

Côme Bommier, Jérôme Lambert, Grzegorz Nowakowski, Emanuele Zucca, Catherine Thieblemont

DOI: 10.1097/HS9.0000000000000680 En savoir plus

Lysa 2022_LYSA_PET imaging: back in the game for gastric EMZL?

Anne-Ségolène Cottereau

doi: 10.1182/blood.2021013964. En savoir plus

Lysa 2022_LYSA_Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study

René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspasia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Franck Morschhauser, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi

J Clin Oncol 2022 Jan 6;JCO2101777. doi: 10.1200/JCO.21.01777 En savoir plus

Lysa 2022_LYSA_Obinutuzumab plus lenalidomide (GALEN) in advanced, previously untreated follicular lymphoma in need of systemic therapy

Emmanuel Bachy, Roch Houot, Pierre Feugier, Krimo Bouabdallah, Reda Bouabdallah, Emmanuelle Nicolas-Virelizier, Marie M F Maerevoet, Christophe Fruchart, Sylvia Snauwaert, Steven Le Gouill, Jean-Pierre Marolleau, Lysiane Molina, Cécile Moluçon Chabrot, Catherine Thieblemont, Herve Tilly, Fontanet Bijou, Corinne Haioun, Eric W Van Den Neste, Bettina Fabiani, Michel Meignan, Guillaume Cartron, Gilles Andre Salles, Rene-Olivier Casasnovas, Franck Morschhauser

Blood . 2022 Apr 14;139(15):2338-2346. En savoir plus

Publications scientifiques LYSA

Publications 2022